Small distinctions in the cell line, the manufacturing process
or the surrounding environment can make a major difference in side
effects observed during treatment, i.e. two similar biologics can
trigger very different immunogenic response. Therefore, and unlike
chemical pharmaceuticals, substitution between biologics, including
biosimilars, can have clinical consequences and does create
putative health concerns.